Heron Therapeutics Inc (HRTX)

Operating Expenses

$116.80M

TTM · Period ending: · USD

HRTX logo

HRTX Operating Expenses

Latest reported$116.80M
HRTX TTM Operating Expenses (-$4.80M → $116.80M)
High-resolution chart · PNG

HRTX operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Heron Therapeutics Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
116,799,000
117,641,000
116,095,000
109,574,000
110,462,000
113,433,000
117,165,000
125,353,000
135,698,000
157,754,000
172,554,000
175,742,000
191,309,000
198,255,000
227,456,000
252,951,000
262,816,000
270,253,000
258,153,000
267,411,000
275,003,000
276,025,000
280,612,000
286,674,000
275,777,000
281,215,000
295,043,000
285,058,000
278,766,000
254,815,000
233,899,000
235,918,000
230,763,000
229,416,000
220,737,000
198,179,000
197,078,000
190,592,000
156,067,000
122,817,000
97,574,000
77,522,000
80,662,000
85,360,000
81,822,000
77,599,000
74,561,000
62,143,000
55,854,000
52,272,000
40,562,000
36,961,000
26,725,000
15,896,000
15,053,000
15,695,000
17,356,000
14,767,000
11,708,000
9,502,000
7,399,000
9,833,000
11,235,000
11,545,000
11,889,000
11,638,000
11,503,000
13,133,000
17,144,000
19,571,000
23,814,000
27,910,000
26,926,000
25,160,000
24,090,000
21,868,000
20,459,000
20,613,000
18,864,000
17,257,000
16,483,000
15,595,000
13,865,000
13,566,000
13,808,000
13,632,000
14,720,000
13,776,000
12,863,000
12,239,000
11,460,000
10,958,000
11,133,000
10,841,000
10,004,000
10,867,000
11,003,000
10,603,000
10,651,000
9,739,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.